This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5egm
From Proteopedia
| Line 1: | Line 1: | ||
==Development of a novel tricyclic class of potent and selective FIXa inhibitors== | ==Development of a novel tricyclic class of potent and selective FIXa inhibitors== | ||
| - | <StructureSection load='5egm' size='340' side='right' caption='[[5egm]], [[Resolution|resolution]] 1.84Å' scene=''> | + | <StructureSection load='5egm' size='340' side='right'caption='[[5egm]], [[Resolution|resolution]] 1.84Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5egm]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5egm]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EGM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5EGM FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5NY:2-CHLORANYL-~{N}-[(7~{S})-2-METHYL-7-PHENYL-10-(1~{H}-1,2,3,4-TETRAZOL-5-YL)-8,9-DIHYDRO-6~{H}-PYRIDO[1,2-A]INDOL-7-YL]-4-(1,2,4-TRIAZOL-4-YL)BENZAMIDE'>5NY</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=NHE:2-[N-CYCLOHEXYLAMINO]ETHANE+SULFONIC+ACID'>NHE</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.841Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5NY:2-CHLORANYL-~{N}-[(7~{S})-2-METHYL-7-PHENYL-10-(1~{H}-1,2,3,4-TETRAZOL-5-YL)-8,9-DIHYDRO-6~{H}-PYRIDO[1,2-A]INDOL-7-YL]-4-(1,2,4-TRIAZOL-4-YL)BENZAMIDE'>5NY</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=NHE:2-[N-CYCLOHEXYLAMINO]ETHANE+SULFONIC+ACID'>NHE</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5egm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5egm OCA], [https://pdbe.org/5egm PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5egm RCSB], [https://www.ebi.ac.uk/pdbsum/5egm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5egm ProSAT]</span></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/FA9_HUMAN FA9_HUMAN] Defects in F9 are the cause of recessive X-linked hemophilia B (HEMB) [MIM:[https://omim.org/entry/306900 306900]; also known as Christmas disease.<ref>PMID:8295821</ref> <ref>PMID:2592373</ref> <ref>PMID:2743975</ref> <ref>PMID:6603618</ref> <ref>PMID:3009023</ref> <ref>PMID:3790720</ref> <ref>PMID:3401602</ref> <ref>PMID:3243764</ref> <ref>PMID:2713493</ref> <ref>PMID:2714791</ref> <ref>PMID:2773937</ref> <ref>PMID:2775660</ref> <ref>PMID:2753873</ref> <ref>PMID:2738071</ref> <ref>PMID:2472424</ref> <ref>PMID:2339358</ref> <ref>PMID:2372509</ref> <ref>PMID:2162822</ref> <ref>PMID:1958666</ref> <ref>PMID:1902289</ref> <ref>PMID:1346975</ref> <ref>PMID:1615485</ref> <ref>PMID:8257988</ref> <ref>PMID:8076946</ref> <ref>PMID:8199596</ref> <ref>PMID:7981722</ref> <ref>PMID:8680410</ref> <ref>PMID:9222764</ref> <ref>PMID:9590153</ref> <ref>PMID:9452115</ref> <ref>PMID:9600455</ref> <ref>PMID:10698280</ref> <ref>PMID:10094553</ref> <ref>PMID:11122099</ref> <ref>PMID:12588353</ref> <ref>PMID:12604421</ref> Note=Mutations in position 43 (Oxford-3, San Dimas) and 46 (Cambridge) prevents cleavage of the propeptide, mutation in position 93 (Alabama) probably fails to bind to cell membranes, mutation in position 191 (Chapel-Hill) or in position 226 (Nagoya OR Hilo) prevent cleavage of the activation peptide. Defects in F9 are the cause of thrombophilia due to factor IX defect (THPH8) [MIM:[https://omim.org/entry/300807 300807]. A hemostatic disorder characterized by a tendency to thrombosis.<ref>PMID:19846852</ref> |
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/FA9_HUMAN FA9_HUMAN] Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 21: | ||
</div> | </div> | ||
<div class="pdbe-citations 5egm" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5egm" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Factor IX 3D structures|Factor IX 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Andre | + | [[Category: Andre P]] |
| - | [[Category: Araki | + | [[Category: Araki K]] |
| - | [[Category: Bateman | + | [[Category: Bateman TJ]] |
| - | [[Category: Berger | + | [[Category: Berger R]] |
| - | [[Category: Campeau | + | [[Category: Campeau L]] |
| - | [[Category: Chen | + | [[Category: Chen Y]] |
| - | [[Category: Desai | + | [[Category: Desai K]] |
| - | [[Category: Dewnani | + | [[Category: Dewnani S]] |
| - | [[Category: Ellsworth | + | [[Category: Ellsworth K]] |
| - | [[Category: Feng | + | [[Category: Feng D]] |
| - | [[Category: Geissler | + | [[Category: Geissler WM]] |
| - | [[Category: Guo | + | [[Category: Guo L]] |
| - | [[Category: Hirabayashi | + | [[Category: Hirabayashi T]] |
| - | [[Category: Hruza | + | [[Category: Hruza A]] |
| - | [[Category: Jian | + | [[Category: Jian T]] |
| - | [[Category: Li | + | [[Category: Li H]] |
| - | [[Category: McCabe-Dunn | + | [[Category: McCabe-Dunn j]] |
| - | [[Category: Meng | + | [[Category: Meng D]] |
| - | [[Category: Nishimura | + | [[Category: Nishimura T]] |
| - | [[Category: Orr | + | [[Category: Orr R]] |
| - | [[Category: Parker | + | [[Category: Parker DL]] |
| - | [[Category: Poirier | + | [[Category: Poirier M]] |
| - | [[Category: Reichert | + | [[Category: Reichert P]] |
| - | [[Category: Sakurada | + | [[Category: Sakurada I]] |
| - | [[Category: Sherer | + | [[Category: Sherer EC]] |
| - | [[Category: Smith | + | [[Category: Smith CJ]] |
| - | [[Category: Sonatore | + | [[Category: Sonatore LM]] |
| - | [[Category: Tschirret-Guth | + | [[Category: Tschirret-Guth R]] |
| - | [[Category: Wood | + | [[Category: Wood HB]] |
| - | [[Category: Wu | + | [[Category: Wu J]] |
| - | [[Category: Xu | + | [[Category: Xu J]] |
| - | [[Category: Zhang | + | [[Category: Zhang T]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Development of a novel tricyclic class of potent and selective FIXa inhibitors
| |||||||||||
Categories: Homo sapiens | Large Structures | Andre P | Araki K | Bateman TJ | Berger R | Campeau L | Chen Y | Desai K | Dewnani S | Ellsworth K | Feng D | Geissler WM | Guo L | Hirabayashi T | Hruza A | Jian T | Li H | McCabe-Dunn j | Meng D | Nishimura T | Orr R | Parker DL | Poirier M | Reichert P | Sakurada I | Sherer EC | Smith CJ | Sonatore LM | Tschirret-Guth R | Wood HB | Wu J | Xu J | Zhang T
